Sitrin Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.79M Sell
5,864
-80
-1% -$94.4K 3.06% 17
2026
Q2
$7.13M Sell
5,944
-75
-1% -$76.6K 3.16% 11
2026
Q1
$5.54M Buy
6,019
+3
+0% +$3.04K 2.77% 21
2025
Q4
$6.47M Sell
6,016
-4
-0.1% -$3.82K 3.07% 13
2025
Q3
$4.59M Sell
6,020
-58
-1% -$43.2K 2.2% 27
2025
Q2
$4.74M Sell
6,078
-566
-9% -$440K 2.42% 25
2025
Q1
$5.49M Buy
6,644
+22
+0.3% +$18.3K 2.96% 18
2024
Q4
$5.11M Buy
6,622
+27
+0.4% +$22.4K 2.58% 20
2024
Q3
$5.84M Sell
6,595
-17
-0.3% -$15.3K 2.92% 18
2024
Q2
$5.99M Buy
+6,612
New +$5.29M 3.18% 15

Other funds holding LLY

Sitrin Capital Management's LLY Position: Q3 2026 in Review

Sitrin Capital Management reduced its Eli Lilly (LLY) stake by 1.3% in Q3 2026, selling an estimated $94.4K and leaving 5,864 shares worth $6.79M. The position accounts for 3.06% of the portfolio, ranked #17.

Sitrin Capital Management first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. The position peaked at $7.13M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Sitrin Capital Management held 5,864 shares of Eli Lilly worth $6.79M as of Q3 2026.
  • Sitrin Capital Management sold 80 Eli Lilly shares in Q3 2026, an estimated $94.4K.
  • Eli Lilly made up 3.06% of Sitrin Capital Management's portfolio in Q3 2026, its #17 holding.
  • Sitrin Capital Management first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
  • Sitrin Capital Management's Eli Lilly position peaked at $7.13M in Q2 2026.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Sitrin Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.